Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
February 20, 2026 15:10 ET | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British…
Phemex Completes Full Integration of Ondo Finance Tokenized Equity Suite
APIA, Samoa, Feb. 20, 2026 /PRNewswire/ -- Phemex, a user-first crypto exchange,…
GigaCloud Technology Inc to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 26, 2026
February 19, 2026 08:05 ET | Source: GigaCloud Technology EL MONTE, Calif.,…
Swiggy Dineout Onboards Bhuvan Bam as GIRF 2026 Ambassador; Brings BB Ki Vines Characters to Life with ‘Bill Half. Party Full.’
GIRF 2026 (Great Indian Restaurant Festival) to be live from February 15,…
New BrowserStack Report Finds 94% of Teams Use AI in Testing, but Only 12% Have Reached Full Autonomy
DUBLIN, Feb. 10, 2026 /PRNewswire/ -- BrowserStack today released its State of AI…
ChipMOS Schedules Fourth Quarter and Full Year 2025 Financial Results Conference Call
February 04, 2026 05:00 ET | Source: ChipMOS TECHNOLOGIES INC. HSINCHU, Taiwan,…
Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ:…
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
January 26, 2026 17:00 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M
January 23, 2026 17:00 ET | Source: Corvus Pharmaceuticals, Inc. SOUTH SAN…
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 22, 2026 16:05 ET | Source: Adaptive Biotechnologies SEATTLE, Jan. 22,…
